Back to "These findings were consistent across su..."
Strong Support
quantitative
Analysis v1
History

For people with clogged arteries who are already on cholesterol drugs, adding a medicine called evolocumab helps lower their risk of heart problems — and it works pretty well even for those who've...

74
Pro
0
Against

Evidence from Studies

Supporting (1)

74

Community contributions welcome

74

Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis

Randomized Controlled Trial
Human
2020 May

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Sign up to see full verdict

Source Study

Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis

Score: 74
DOI: 10.1161/STROKEAHA.119.027759

Similar Assertions

For people with heart disease who are already taking cholesterol-lowering statins but still have high LDL, adding a drug called evolocumab can lower their chances of having a heart attack, stroke, or other serious heart problems by about 15% over two years.

74
0
90%

Even if your cholesterol is already pretty low thanks to statins, adding a drug called evolocumab can still help protect your heart and blood vessels.

74
0
90%

Adding a drug called evolocumab to cholesterol-lowering statins can lower the chances of serious heart problems by 20% in people who already have heart disease.

79
0
89%

Even if someone with heart disease is already taking cholesterol-lowering drugs and their cholesterol is pretty low, adding a drug called evolocumab can still help protect their heart.

74
0
88%

For people with heart disease who are already taking cholesterol-lowering drugs, adding a medicine called evolocumab can lower their chance of having a heart attack, stroke, or other serious heart problems by about 15% over two years.

74
0
88%